| RSTS | retropharyngeal soft tissue space |
|---|---|
| SCID | severe combined immunodeficiency [syndrome]; soft copy image display; Structured Clinical Interview ... |
| SCL | scleroderma; serum copper level; sinus cycle length; soft contact lens; stromal cell line; subcostal... |
| SEC | secretin; Singapore epidemic conjunctivitis; soft elastic capsule |
| SEG | segment; soft elastic gelatin; sonoencephalogram |
| nasion soft tissue | The outer point of intersection between the nasion-sella line and the soft tissue profile. (05 Mar 2000) |
|---|---|
| neoplasms, connective and soft tissue | Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue. (12 Dec 1998) |
| tensor muscle of soft palate | <anatomy> Tensor muscle of soft palate, musculus tensor palati; musculus palatosalpingeus; musculus sphenosalpingostaphylinus; dilator tubae; origin, scaphoid fossa of sphenoid, cartilaginous and membranous part of auditory (eustachian) tube and spine of sphenoid; insertion, posterior border of hard palate and aponeurosis of soft palate; action, tenses the soft palate; contributes to opening of auditory tube; nerve supply, branches of trigeminal nerve through the otic ganglion. Synonym: musculus tensor veli palatini, dilator tubae, musculus palatosalpingeus, musculus sphenosalpingostaphylinus, musculus tensor palati, palatosalpingeus, tensor muscle of soft palate. (05 Mar 2000) |
| elevator muscle of soft palate | <anatomy, muscle> Origin, apex of petrous portion of temporal bone and lower part of cartilaginous auditory (eustachian) tube; insertion, aponeurosis of soft palate; action, raises soft palate; through the expansion of its fleshy belly during contraction, it helps to "push" open the auditory tube; nerve supply, pharyngeal plexus (cranial root of accessory nerve). Synonym: musculus levator veli palatini, elevator muscle of soft palate, levator palati muscle, musculus levator palati, musculus petrostaphylinus. (05 Mar 2000) |
| yellow soft paraffin | <pharmacology> A semisolid unctuous substance, neutral, and without taste or odour, derived from petroleum by distilling off the lighter portions and purifying the residue. It is a yellowish, fatlike mass, transparent in thin layers, and somewhat fluorescent. It is used as a bland protective dressing, and as a substitute for fatty materials in ointments. Petrolatum is the official name for the purified product. Cosmoline and vaseline are commercial names for substances essentially the same, but differing slightly in appearance and consistency or fusibility. Source: Websters Dictionary (01 Mar 1998) |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
| bone cancer | <oncology> A general term to imply malignant tumour growth in bone. (27 Sep 1997) |
| bovine cancer eye | A malignant squamous cell carcinoma of cattle, especially the Hereford breed, that originates in the conjunctival mucous membranes or the surrounding skin; it occurs principally in range cattle having unpigmented skin around the eye and living in regions of intense sunlight. (05 Mar 2000) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| breast cancer | <oncology> The uncontrolled growth of malignant breast tissue. Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group. Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer. Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography. WWW: cancerNET document for patients WWW: cancerNET document for clinicians (05 Jan 1998) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| buyo cheek cancer | betel cancer |
| cancer | <oncology> The first historical description of this condition was in relation to breast carcinoma. This is now a general term for more than 100 diseases that are characterised by uncontrolled, abnormal growth of cells. Cancer cells can spread locally or through the bloodstream and lymphatic system to other parts of the body. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|